April 23, 2020

COVID-19: Melatonin as a potential adjuvant treatment

Category: Article Summary

Topic: Testing and Treatment

• Zhang et al speculate on the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. Although the direct evidence of melatonin application in COVID-19 is unclear, both its use in experimental animal models and in studies on humans has continuously documented its efficacy and safety, and its role in limiting virus-related diseases.

Zhang et al. (Mar 23, 2020). COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. https://doi.org/10.1016/j.lfs.2020.117583